# Sen-Jam Update: NYSE Ticker Symbol Reservation | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/348522
- Entity ID: wefunder:feed_item:348522
- Published at: 2026-07-07 02:41:37 UTC
- Updated at: 2026-07-08 06:48:22 UTC

## Author
Jim Iversen

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Community,We wanted to share a brief administrative update with our community.With the help of our Strategic Advisor, Dr. Alexander Wissner-Gross, and Brian Baumann at the New York Stock Exchange, Sen-Jam has reserved the ticker symbol SNJM for potential future use.To be clear, the reservation of a ticker symbol is an administrative action. It does not mean Sen-Jam is pursuing an initial public offering, applying to list on the New York Stock Exchange, or taking any step toward becoming a publicly traded company at this time. Sen-Jam is not currently listed or traded on the New York Stock Exchange, and no inference should be drawn regarding any future public offering, exchange listing, or liquidity event.We do view this as another opportunity to continue building relationships, strengthening our communication, and sharing Sen-Jam’s broader story with the healthcare, innovation, and life sciences communities. Our focus remains where it has always been: advancing our science, developing our pipeline, building the Galaxy computational platform, engaging with regulators and partners, and pursuing our mission with discipline and purpose.That mission has not changed: increase speed-to-patient, lower the cost of therapeutic development, and make meaningful medicines available to everyone on the planet.For those who would like to learn more about the broader vision we are building, our Galaxy video (7 min) provides a helpful overview: Sen-Jam Galaxy Video.We are also grateful to be participating in upcoming NYSE ecosystem programming, including the AI x Bio Summit and I'll be joining NYSE Wired – MedTech Unplugged on July 23rd. These opportunities allow us to continue learning, engaging, and sharing our work within a broader healthcare and innovation community.Thank you to Dr. Alexander Wissner-Gross for helping catalyze this opportunity, and to Brian Baumann, Dr. Eric Dimise, and Dr. Johanna Grossman for welcoming Sen-Jam into the NYSE ecosystem.The future belongs to the resilient.With gratitude,JimDisclosureThis communication is for informational purposes only and does not constitute, and shall not be construed as, an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. This communication is not intended to, and does not, condition the market for any securities of Sen-Jam Pharmaceutical, Inc. (the “Company”) or promote any current or future offering of securities. The reservation of a ticker symbol is an administrative action by the New York Stock Exchange and does not constitute approval of any listing application or guarantee that the Company will complete an initial public offering, list any securities on the New York Stock Exchange or any other securities exchange, or otherwise become a publicly traded company. The Company is not currently listed or traded on the New York Stock Exchange. The Company has no current plans to conduct an initial public offering, and no assurance can be given that any public offering, exchange listing, or other liquidity event will occur.